The need for increased capacity in local drug production has been well recognised. Such capacity should cover the production of raw materials and intermediate products, not just formulation and packaging. Drug production facilities in the country are presently operating under severe constraints, including the following:
• poor infrastructural facilities such as water and electricity supply,
• poor transportation and communication,
• poor waste disposal management,
• inadequate incentives such as tax relief, capital allowance, and government patronage
• limited access to funds for capital development,
• unfair competition by imported drugs, and
• reliance on imported raw materials, machinery and spare parts.
In order to achieve the target of greater reliance on local drug production, steps shall be taken by government to:
i. Encourage the development of a stable economic and political environment;
ii. Intensify efforts to improve basic infrastructure and facilities;
iii. Provide an efficient regulatory environment;
iv. Provide favourable tax, interest rate regime and duty structures for locally manufactured products and imported raw materials, as well as for drug packaging materials;
v. Intensify efforts to ensure that the petrochemical and other essential industries for the proper development of the pharmaceutical manufacturing industry come on stream;
vi. Encourage research on pharmaceutical raw materials;
vii. Promote the development of associated industries for the production of materials, such as plastics, glass, paper, aluminium foil, etc., which are essential for drug packaging;
viii. Encourage patronage of local drug manufacturers by public and private health care institutions;
ix. Provide grants for the establishment of plants for the production of basic raw materials.
x. Encourage small-scale pharmaceutical production.